SKU: T14521-500mg-TM
BDP9066
Blue Ice
Specifications
| Specification | Details |
|---|---|
| Additional Information | BDP9066 has therapeutic effect on skin cancer by reducing substrate phosphorylation. BDP9066 is a potent and selective myotonic dystrophy-related Cdc42-binding kinase MRCK inhibitor. With an IC50 of 64 nM for MRCKβ in SCC12 cells, Ki values of 0.0136 nM and 0.0233 nM for MRCKα/β in house determinations, respectively. |
Resources
PDF
Datasheet
Catalog Number
T14521-500mg-TM
Name
BDP9066
Price(500 mg)
Pack Size